{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T16:47:14Z","timestamp":1781714834782,"version":"3.54.5"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,12]]},"DOI":"10.7759\/cureus.94378","type":"journal-article","created":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:59:32Z","timestamp":1760259572000},"source":"Crossref","is-referenced-by-count":2,"title":["Sodium Valproate-Induced Bicytopenia: A Case Report"],"prefix":"10.7759","author":[{"given":"Alexander J","family":"Skingle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Go","family":"Bin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Valproic acid","author":"Rahman M","year":"2024","unstructured":"Rahman M, Awosika AO, Nguyen H. Valproic acid. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2024."},{"key":"ref2","unstructured":"British National Formulary. Epilepsy. (2025). Accessed: September 12 2025: https:\/\/bnf.nice.org.uk\/treatment-summaries\/epilepsy\/."},{"key":"ref3","unstructured":"British National Formulary. sodium valproate. (2025). Accessed: September 12, 2025: https:\/\/bnf.nice.org.uk\/drugs\/sodium-valproate\/."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/JNN.0000000000000259","article-title":"Valproic acid: special considerations and targeted monitoring","volume":"49","author":"Collins-Yoder A","year":"2017","unstructured":"Collins-Yoder A, Lowell J. Valproic acid: special considerations and targeted monitoring. J Neurosci Nurs. 2017, 49:56-61. 10.1097\/JNN.0000000000000259","journal-title":"J Neurosci Nurs"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2008.01561.x","article-title":"Antiepileptic drugs--best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies","volume":"49","author":"Patsalos PN","year":"2008","unstructured":"Patsalos PN, Berry DJ, Bourgeois BF, et al.. Antiepileptic drugs--best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies. Epilepsia. 2008, 49:1239-76. 10.1111\/j.1528-1167.2008.01561.x","journal-title":"Epilepsia"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-200001000-00012","article-title":"Hematologic toxicity of sodium valproate","volume":"22","author":"Acharya S","year":"2000","unstructured":"Acharya S, Bussel JB. Hematologic toxicity of sodium valproate. J Pediatr Hematol Oncol. 2000, 22:62-5. 10.1097\/00043426-200001000-00012","journal-title":"J Pediatr Hematol Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-199701000-00011","article-title":"Trilineage hematopoietic toxicity associated with valproic acid therapy","volume":"19","author":"Bottom KS","year":"1997","unstructured":"Bottom KS, Adams DM, Mann KP, Ware RE. Trilineage hematopoietic toxicity associated with valproic acid therapy. J Pediatr Hematol Oncol. 1997, 19:73-6. 10.1097\/00043426-199701000-00011","journal-title":"J Pediatr Hematol Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/BF01956425","article-title":"Haematological disturbances during long-term valproate therapy","volume":"153","author":"Brichard B","year":"1994","unstructured":"Brichard B, Vermylen C, Scheiff JM, Ninane J, Cornu G. Haematological disturbances during long-term valproate therapy. Eur J Pediatr. 1994, 153:378-80. 10.1007\/BF01956425","journal-title":"Eur J Pediatr"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.65670","article-title":"Valproate-induced thrombocytopenia: a case report","volume":"16","author":"Surineni K","year":"2024","unstructured":"Surineni K, Wells E, Schrader N, Costa G, Ziegler M. Valproate-induced thrombocytopenia: a case report. Cureus. 2024, 16:e65670. 10.7759\/cureus.65670","journal-title":"Cureus"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1592\/phco.21.17.1325.34418","article-title":"Prevalence and risk of thrombocytopenia with valproic acid: experience at a psychiatric teaching hospital","volume":"21","author":"Conley EL","year":"2001","unstructured":"Conley EL, Coley KC, Pollock BG, Dapos SV, Maxwell R, Branch RA. Prevalence and risk of thrombocytopenia with valproic acid: experience at a psychiatric teaching hospital. Pharmacotherapy. 2001, 21:1325-30. 10.1592\/phco.21.17.1325.34418","journal-title":"Pharmacotherapy"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1993.tb02139.x","article-title":"Hematologic manifestations of long-term valproate therapy","volume":"34","author":"May RB","year":"1993","unstructured":"May RB, Sunder TR. Hematologic manifestations of long-term valproate therapy. Epilepsia. 1993, 34:1098-101. 10.1111\/j.1528-1157.1993.tb02139.x","journal-title":"Epilepsia"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22891\u00a0","article-title":"Valproic acid for the treatment of myeloid malignancies","volume":"110","author":"Kuendgen A","year":"2007","unstructured":"Kuendgen A, Gattermann N. Valproic acid for the treatment of myeloid malignancies. Cancer. 2007, 110:943-54. 10.1002\/cncr.22891\u00a0","journal-title":"Cancer"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2165\/10898530-000000000-00000","article-title":"Seizure outcomes following the use of generic versus brand-name antiepileptic drugs: a systematic review and meta-analysis","volume":"70","author":"Kesselheim AS","year":"2010","unstructured":"Kesselheim AS, Stedman MR, Bubrick EJ, et al.. Seizure outcomes following the use of generic versus brand-name antiepileptic drugs: a systematic review and meta-analysis. Drugs. 2010, 70:605-21. 10.2165\/10898530-000000000-00000","journal-title":"Drugs"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S508553\u00a0","article-title":"Factors influencing medication non-adherence in patients with chronic diseases and disabilities: insights from a national survey in Indonesia","volume":"19","author":"Alfian SD","year":"2025","unstructured":"Alfian SD, Griselda M, Pratama MAA, Insani WN, Abdulah R, Wawruch M. Factors influencing medication non-adherence in patients with chronic diseases and disabilities: insights from a national survey in Indonesia. Patient Prefer Adherence. 2025, 19:1557-72. 10.2147\/PPA.S508553\u00a0","journal-title":"Patient Prefer Adherence"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.862","article-title":"Medication adherence","volume":"57","author":"Lawrence D","year":"2017","unstructured":"Lawrence D, Miller JH, W Flexner C. Medication adherence. J Clin Pharmacol. 2017, 57:422-7. 10.1002\/jcph.862","journal-title":"J Clin Pharmacol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-014-1761-3","article-title":"Knowledge, attitudes and beliefs of patients and carers regarding medication adherence: a review of qualitative literature","volume":"70","author":"Kelly M","year":"2014","unstructured":"Kelly M, McCarthy S, Sahm LJ. Knowledge, attitudes and beliefs of patients and carers regarding medication adherence: a review of qualitative literature. Eur J Clin Pharmacol. 2014, 70:1423-31. 10.1007\/s00228-014-1761-3","journal-title":"Eur J Clin Pharmacol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/419253-sodium-valproate-induced-bicytopenia-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:59:33Z","timestamp":1760259573000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/419253-sodium-valproate-induced-bicytopenia-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,12]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.94378","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,12]]}}}